By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French biotech Genoway said today it has licensed technology from Bluebird Bio to genetically modify rodents.

The license grants Genoway exclusive worldwide rights to Bluebird's RCME technology, which combines a recombinase system with genetic modification, enabling the introduction of a DNA sequence at a specific locus. The technology was developed at the Massachusetts Institute of Technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.